The European Commission has cleared the proposed acquisition by Schering-Plough Corporation of Organon BS, a Dutch subsidiary of Akzo Nobel active in human and animal health. The Commission found that the notified transaction raised competition concerns in 12 veterinary product areas and more than 30 relevant national markets. Schering-Plough therefore proposed to divest the overlapping activities in all the markets where serious doubts were raised. In the light of these commitments, the Commission has concluded that the proposed transaction would not significantly impede effective competition in the European Economic Area.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
Schering-Plough’s acquisition of Organon BS subject to conditions
- McDermott Will & Emery
- Geert Dierickx
- European Union, Netherlands
- October 19 2007
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.
“The Lexology newsfeed is very relevant to my practice and I like that you can tailor the newsfeed to include specific practice areas. I enjoy seeing a variety of approaches and I will read multiple articles on the...
“The Lexology newsfeed is very relevant to my practice and I like that you can tailor the newsfeed to include specific practice areas. I enjoy seeing a variety of approaches and I will read multiple articles on the same topic for the purpose of getting the fullest understanding of a new law, a court case or other legal development.”
Audrey E Mross
Labor & Employment Attorney
Munck Carter LLP